ArticleInternational journal of biological sciences2025

TBK1 inhibitor amlexanox exerts anti-cancer effects against endometrial cancer by regulating AKT/NF-κB signaling.

Jiha Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.